エピジェネティクスの市場規模、シェア、動向分析レポート：製品別、技術別、用途別、最終用途別、地域別、セグメント予測、2024年～2030年

エピジェネティクス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のエピジェネティクス市場規模は2024年から2030年にかけて15.3%のCAGRを記録し、2030年までに391億5,000万米ドルに達すると予測されています。

この市場は、エピジェネティクスの研究開発のための資金調達、投資、規制認可の増加、創薬開発におけるエピジェネティック酵素の使用の拡大、ゲノム配列決定のコスト低下などの要因によって牽引されています。エピジェネティクスは腫瘍以外でも有益な用途を実証しているため、商業的な拡大が想定されます。分子レベルでのエピジェネティックな変化を理解する需要の高まりや、薬物治療の進歩は、おそらくこれらの組織を研究開発プログラムの支援に駆り立てると思われます。

さらに、疫学・ゲノム研究プログラム（EGRP）のようなイニシアチブは、腫瘍の発生と結果についてよりよく理解することを目的とした研究努力にインセンティブを与えます。市場の上昇を後押しするいくつかの組織は、国際ヒトエピゲノムコンソーシアム（IHEC）、米国国立腫瘍研究所（NCI）、米国国立衛生研究所（NIH）です。これらの組織は、エピジェネティクスの分野における製品開発や研究開発を含むイニシアチブに資金を提供し、支援しています。例えば、国立衛生研究所は、共通基金エピゲノミクスプログラムを通じて、最先端のエピジェネティクス研究を世界中で積極的に推進しています。

エピジェネティクス市場レポートハイライト

• 製品別では、試薬セグメントが業界を支配し、2023年の世界収益の33.45%を占めました。このセグメントの大きなシェアは、エピジェネティクス研究における試薬の高い使用率に起因しています。
• 技術別では、DNAメチル化セグメントが2023年の売上高シェア45.36％で市場を独占しました。エピジェネティクスにおけるDNAメチル化の需要は、遺伝子発現制御における極めて重要な役割に由来します。
• 用途別では、腫瘍が2023年の売上高シェア69.06%で市場を独占しました。腫瘍におけるエピジェネティクスの需要は、エピジェネティクスの変化とがん発生との間の複雑な関係から生じています。
• 北米が市場を独占し、2023年のシェアは38.19%でした。この地域は、一般市民の意識の高まり、充実した医療施設、充実した研究開発投資によって成長を遂げています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 エピジェネティクス市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し。
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
  • 市場機会分析
• エピジェネティクス市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 エピジェネティクス市場：製品の推定・動向分析

• セグメントダッシュボード
• 世界のエピジェネティクス市場の製品の動向分析
• 世界のエピジェネティクス市場規模・動向分析、製品別、2018～2030年
• 試薬
• キット
• 機器
• 酵素
• サービス

第5章 エピジェネティクス市場：技術の推定・動向分析

• セグメントダッシュボード
• 世界のエピジェネティクス市場の技術の動向分析
• 世界のエピジェネティクス市場規模・動向分析、技術別、2018～2030年
• DNAメチル化
• ヒストンメチル化
• ヒストンアセチル化
• 大型ノンコーディングRNA
• マイクロRNA修飾
• クロマチン構造

第6章 エピジェネティクス市場：用途の推定・動向分析

• セグメントダッシュボード
• 世界のエピジェネティクス市場の用途の動向分析
• 世界のエピジェネティクス市場規模・動向分析、用途別、2018～2030年
• 腫瘍
• 非腫瘍

第7章 エピジェネティクス市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 世界のエピジェネティクス市場の最終用途の動向分析
• 世界のエピジェネティクス市場規模・動向分析、最終用途別、2018～2030年
• 学術研究
• 臨床研究
• 病院・クリニック
• 製薬・バイオテクノロジー企業
• その他

第8章 エピジェネティクス市場：地域の推定・動向分析

• 地域の市場シェア分析、2023年・2030年
• 地域の市場ダッシュボード
• 市場規模と予測・動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2023年
• 企業プロファイル/上場企業
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Eisai Co., Ltd.
  • Novartis AG
  • ELEMENT BIOSCIENCES.
  • Dovetail Genomics.
  • Illumina, Inc.
  • Promega Corporation
  • Abcam plc

List of Tables

• Table 1 List of abbreviations
• Table 2 Global epigenetics market, by region, 2018 - 2030 (USD Million)
• Table 3 Global epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 4 Global epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 5 Global epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 6 Global epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 7 North America epigenetics market, by country, 2018 - 2030 (USD Million)
• Table 8 North America epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 9 North America epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 10 North America epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 11 North America epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 12 U.S. epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 13 U.S. epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 14 U.S. epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 15 U.S. epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 16 Canada epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 17 Canada epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 18 Canada epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 19 Canada epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 20 Europe epigenetics market, by country, 2018 - 2030 (USD Million)
• Table 21 Europe epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 22 Europe epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 23 Europe epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 24 Europe epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 25 Germany epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 26 Germany epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 27 Germany epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 28 Germany epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 29 UK epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 30 UK epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 31 UK epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 32 UK epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 33 France epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 34 France epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 35 France epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 36 France epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 37 Italy epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 38 Italy epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 39 Italy epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 40 Italy epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 41 Spain epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 42 Spain epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 43 Spain epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 44 Spain epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 45 Denmark epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 46 Denmark epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 47 Denmark epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 48 Denmark epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 49 Sweden epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 50 Sweden epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 51 Sweden epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 52 Sweden epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 53 Norway epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 54 Norway epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 55 Norway epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 56 Norway epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific epigenetics market, by country, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 62 China epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 63 China epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 64 China epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 65 China epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 66 Japan epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 67 Japan epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 68 Japan epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 69 Japan epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 70 India epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 71 India epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 72 India epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 73 India epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 74 South Korea epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 75 South Korea epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 76 South Korea epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 77 South Korea epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 78 Australia epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 79 Australia epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 80 Australia epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 81 Australia epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 82 Thailand epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 83 Thailand epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 84 Thailand epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 85 Thailand epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 86 Latin America epigenetics market, by country, 2018 - 2030 (USD Million)
• Table 87 Latin America epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 88 Latin America epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 89 Latin America epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 90 Latin America epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 91 Brazil epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 92 Brazil epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 93 Brazil epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 94 Brazil epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 95 Mexico epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 96 Mexico epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 97 Mexico epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 98 Mexico epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 99 Argentina epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 100 Argentina epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 101 Argentina epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 102 Argentina epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 103 MEA epigenetics market, by country, 2018 - 2030 (USD Million)
• Table 104 MEA epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 105 MEA epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 106 MEA epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 107 MEA epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 108 South Africa epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 109 South Africa epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 110 South Africa epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 111 South Africa epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 116 UAE epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 117 UAE epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 118 UAE epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 119 UAE epigenetics market, by end-use, 2018 - 2030 (USD Million)
• Table 120 Kuwait epigenetics market, by product, 2018 - 2030 (USD Million)
• Table 121 Kuwait epigenetics market, by technology, 2018 - 2030 (USD Million)
• Table 122 Kuwait epigenetics market, by application, 2018 - 2030 (USD Million)
• Table 123 Kuwait epigenetics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 Epigenetics market: Market outlook
• Fig. 5 Epigenetics market: Segment outlook
• Fig. 6 Epigenetics market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 Epigenetics market driver impact
• Fig. 9 Epigenetics market restraint impact
• Fig. 10 Epigenetics market: Product outlook and key takeaways
• Fig. 11 Epigenetics market: Product movement analysis
• Fig. 12 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 13 Kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 14 ChIP sequencing kit market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 Whole genomic amplification kit market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 16 Bisulfite conversion kit market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 17 RNA sequencing kit market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Epigenetics market: Technology outlook and key takeaways
• Fig. 23 Epigenetics market: Technology movement analysis
• Fig. 24 DNA methylation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Histone methylation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Histone acetylation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Large non-coding RNA market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 MicroRNA modification market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Chromatin structures market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Epigenetics market: Application outlook and key takeaways
• Fig. 31 Epigenetics market: Application movement analysis
• Fig. 32 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Solid tumors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Liquid tumors market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 35 Non-oncology market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 36 Inflammatory diseases market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 37 Metabolic diseases market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 38 Infectious diseases market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 39 Cardiovascular diseases market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Epigenetics market: End-use outlook and key takeaways
• Fig. 42 Epigenetics market: End-use movement analysis
• Fig. 43 Academic research market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Clinical research market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 45 Hospitals & Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 47 Other users market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Global epigenetics market: Regional outlook and key takeaways
• Fig. 49 Global epigenetics market: Regional movement analysis
• Fig. 50 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Epigenetics Market Growth & Trends:

The global epigenetics market size is expected to reach USD 39.15 billion by 2030, registering a CAGR of 15.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is being driven by factors, such as the rise in funding, investment & regulatory approvals for epigenetics research & development, the expansion of the use of epigenetic enzymes in drug discovery & development, and the decreasing cost of genome sequencing. Since epigenetics has demonstrated beneficial applications outside of cancer, commercial expansion is envisaged.The rising demand for understanding epigenetic alterations at the molecular level, as well as the advancement of medicinal treatments, would likely push these organizations to support research and development programs.

Furthermore, initiatives, such as the Epidemiology and Genomics Research Program (EGRP), provide incentives for research efforts aimed at better-comprehending cancer genesis and consequences.A few organizations that help fuel the market's rise are the International Human Epigenome Consortium (IHEC), the National Cancer Institute (NCI), and the National Institutes of Health (NIH). These organizations support funding and help for initiatives involving product development and R&D in the field of epigenetics. For instance, the National Institutes of Health aggressively promotes cutting-edge epigenetic research worldwide through its common fund epigenomics program.

Epigenetics Market Report Highlights:

• By product, the reagents segment dominated the industry, accounting for 33.45% of the global revenue in 2023. The large share of this segment can be attributed to the high usage of reagents in epigenetic research studies.
• By technology, the DNA methylation segment dominated the market with a revenue share of 45.36% in 2023. DNA methylation's demand in epigenetics stems from its pivotal role in gene expression regulation.
• By application, the oncology segment dominated the market with a revenue share of 69.06% in 2023. Oncology's demand for epigenetics arises from the intricate relationship between epigenetic alterations and cancer development.
• North America dominated the market and accounted for a 38.19% share in 2023. The region experiences growth due to heightened public awareness, robust medical facilities, and substantial R&D investments.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Technology
  • 1.2.3. Application
  • 1.2.4. End-use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives
  • 1.10.1. Objective - 1
  • 1.10.2. Objective - 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Epigenetics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of cancer
    • 3.2.1.2. Rising geriatric patient population
    • 3.2.1.3. Increasing government initiatives
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of standardization in epigenetics-based diagnostics
    • 3.2.2.2. Lack of skilled professionals
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Improving healthcare infrastructure in developing economies
• 3.3. Epigenetics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Epigenetics Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Epigenetics Market Product Movement Analysis
• 4.3. Global Epigenetics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Reagents
  • 4.4.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Kits
  • 4.5.1. Kits market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. ChIP sequencing Kit
    • 4.5.2.1. ChIP sequencing kit market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Whole Genomic Amplification Kit
    • 4.5.3.1. Whole genomic amplification kit market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.4. Bisulfite Conversion Kit
    • 4.5.4.1. Bisulfite conversion kit market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.5. RNA sequencing Kit
    • 4.5.5.1. RNA sequencing kit market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.6. Others
    • 4.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Instruments
  • 4.6.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Enzymes
  • 4.7.1. Enzymes market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Services
  • 4.8.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Epigenetics Market: Technology Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Epigenetics Market Technology Movement Analysis
• 5.3. Global Epigenetics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
• 5.4. DNA Methylation
  • 5.4.1. DNA methylation market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Histone Methylation
  • 5.5.1. Histone methylation market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Histone Acetylation
  • 5.6.1. Histone Acetylation Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Large non-coding RNA
  • 5.7.1. Large non-coding RNA market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. MicroRNA modification
  • 5.8.1. MicroRNA modification market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Chromatin structures
  • 5.9.1. Chromatin structures market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Epigenetics Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Epigenetics Market Application Movement Analysis
• 6.3. Global Epigenetics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Oncology
  • 6.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Solid tumors
    • 6.4.2.1. Solid tumors market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Liquid tumors
    • 6.4.3.1. Liquid tumors market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Non-oncology
  • 6.5.1. Non-oncology Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Inflammatory diseases
    • 6.5.2.1. Inflammatory diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. Metabolic diseases
    • 6.5.3.1. Metabolic diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Infectious diseases
    • 6.5.4.1. Infectious diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.5. Cardiovascular diseases
    • 6.5.5.1. Cardiovascular diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.6. Others
    • 6.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Epigenetics Market: End-use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Epigenetics Market End-use Movement Analysis
• 7.3. Global Epigenetics Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 7.4. Academic Research
  • 7.4.1. Academic research market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Clinical Research
  • 7.5.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Hospitals & Clinics
  • 7.6.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Pharmaceutical & Biotechnology Companies
  • 7.7.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Other Users
  • 7.8.1. Other users market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Epigenetics Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 8.4. North America
  • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Target disease prevalence
    • 8.4.2.4. Competitive scenario
    • 8.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Target disease prevalence
    • 8.4.3.4. Competitive scenario
    • 8.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Target disease prevalence
    • 8.5.2.4. Competitive scenario
    • 8.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Target disease prevalence
    • 8.5.3.4. Competitive scenario
    • 8.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Target disease prevalence
    • 8.5.4.4. Competitive scenario
    • 8.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework
    • 8.5.5.3. Target disease prevalence
    • 8.5.5.4. Competitive scenario
    • 8.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework
    • 8.5.6.3. Target disease prevalence
    • 8.5.6.4. Competitive scenario
    • 8.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.7. Norway
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Regulatory framework
    • 8.5.7.3. Target disease prevalence
    • 8.5.7.4. Competitive scenario
    • 8.5.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Target disease prevalence
    • 8.5.8.3. Regulatory framework
    • 8.5.8.4. Competitive scenario
    • 8.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.9. Denmark
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Regulatory framework
    • 8.5.9.3. Target disease prevalence
    • 8.5.9.4. Competitive scenario
    • 8.5.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Target disease prevalence
    • 8.6.2.4. Competitive scenario
    • 8.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Target disease prevalence
    • 8.6.3.4. Competitive scenario
    • 8.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Target disease prevalence
    • 8.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework
    • 8.6.5.3. Target disease prevalence
    • 8.6.5.4. Competitive scenario
    • 8.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework
    • 8.6.6.3. Target disease prevalence
    • 8.6.6.4. Competitive scenario
    • 8.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Target disease prevalence
    • 8.6.7.3. Regulatory framework
    • 8.6.7.4. Competitive scenario
    • 8.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Target disease prevalence
    • 8.7.2.4. Competitive scenario
    • 8.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. Mexico
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework
    • 8.7.3.3. Target disease prevalence
    • 8.7.3.4. Competitive scenario
    • 8.7.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Argentina
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework
    • 8.7.4.3. Target disease prevalence
    • 8.7.4.4. Competitive scenario
    • 8.7.4.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Target disease prevalence
    • 8.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Regulatory framework
    • 8.8.3.3. Target disease prevalence
    • 8.8.3.4. Competitive scenario
    • 8.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Regulatory framework
    • 8.8.4.3. Target disease prevalence
    • 8.8.4.4. Competitive scenario
    • 8.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Regulatory framework
    • 8.8.5.3. Target disease prevalence
    • 8.8.5.4. Competitive scenario
    • 8.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2023
• 9.4. Company Profiles/Listing
  • 9.4.1. F. Hoffmann-La Roche Ltd
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Thermo Fisher Scientific Inc.
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Eisai Co., Ltd.
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Novartis AG
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. ELEMENT BIOSCIENCES.
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Dovetail Genomics.
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Illumina, Inc.
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Promega Corporation
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. Abcam plc
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives